The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Is a Potent Inhibitor of ATM- and DNA-PKCs-Mediated DNA Damage Responses

Inhibitors of PI3K/Akt signaling are being actively developed for tumor therapy owing to the frequent mutational activation of the PI3K-Akt-mTORC1 pathway in many cancers, including glioblastomas (GBMs). NVP-BEZ235 is a novel and potent dual PI3K/mTOR inhibitor that is currently in phase 1/2 clinica...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mukherjee, Bipasha, Tomimatsu, Nozomi, Amancherla, Kaushik, Camacho, Cristel V, Pichamoorthy, Nandini, Burma, Sandeep
Format: Artigo
Langue:Inglês
Publié: Neoplasia Press Inc. 2012
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3281940/
https://ncbi.nlm.nih.gov/pubmed/22355272
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires